Vladimir V Senatorov, Jr

Title: **Vladimir V Senatorov, Jr: A Pioneer in EP2 Antagonist Compounds**

Introduction

Vladimir V Senatorov, Jr. is an innovative inventor based in Oakland, California. He has made significant contributions to the field of pharmaceutical sciences, focusing on EP2 antagonist compounds which have implications for treating various diseases and conditions associated with EP2 activity.

Latest Patents

Senatorov holds one patent that encapsulates his groundbreaking work. The patent describes compounds that are EP2 antagonists, the methods of making these compounds, pharmaceutical compositions, and the use of these compounds in medicinal applications. This innovation is particularly relevant for developing new therapeutic strategies for conditions linked to EP2 activity.

Career Highlights

Currently, Vladimir V Senatorov, Jr. is an integral part of Reservoir Neuroscience, Inc., where he leverages his expertise in neuroscience and pharmaceuticals. His work there highlights his dedication to advancing our understanding and treatment of neurological disorders through innovative medication development.

Collaborations

Throughout his career, Senatorov has collaborated with notable professionals in the field, including Matthew Alexander James Duncton and Aaron R. Friedman. These partnerships underscore a commitment to research excellence and a collaborative spirit essential for scientific breakthroughs.

Conclusion

Vladimir V Senatorov, Jr. is a distinguished inventor contributing to the advancement of pharmaceutical sciences with his innovative work on EP2 antagonist compounds. His ongoing efforts at Reservoir Neuroscience, Inc. and collaboration with esteemed colleagues illustrate his position as a key figure in the quest for novel therapeutic solutions.